The impact of HLA-A and -DRB1 on age at onset, disease course and severity in Scandinavian multiple sclerosis patients

European Journal of Neurology

Volumn 14, Issue 8, 2007, Pages 835-840

  Smestad, C ^a   Brynedal, B ^b   Jonasdottir, G ^b   Lorentzen, A R ^a,c   Masterman, T ^b   Akesson E ^b   Spurkland, A ^c   Lie, B A ^d   Palmgren, J ^b   Celius, E G ^a   Hillert, J ^b   Harbo, H F ^a,c  

^a ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^b KAROLINSKA INSTITUTE   (Sweden)

^c UNIVERSITY OF OSLO   (Norway)

^d OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

Clinical; HLA A; HLA DRB1; Multiple sclerosis; Scandinavia

Indexed keywords

HLA DQ ANTIGEN; HLA DQ6 ANTIGEN; HLA DR ANTIGEN; HLA DR15 ANTIGEN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE COURSE; DISEASE SEVERITY; FEMALE; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; HUMAN; KRUSKAL WALLIS TEST; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; NORWAY; ONSET AGE; PHENOTYPE; PRIORITY JOURNAL; REGRESSION ANALYSIS; SCANDINAVIA; SWEDEN;

EID: 34547223570     PISSN: 13515101     EISSN: 14681331     Source Type: Journal    
DOI: 10.1111/j.1468-1331.2007.01825.x     Document Type: Article

References (38)

1. Jersild C, Fog T. 1972 Histocompatibility (HL-A) antigens associated with multiple sclerosis. Acta Neurologica Scandinavica Supplementum 51 : 377.
2. Compston A, Confavreux C, Lassmann H, et al. McAlpine's Multiple Sclerosis. Philadelphia, PA : Churchill Livingstone Elsevier, 2005.
3. Sawcer S, Ban M, Maranian M, et al. A high-density screen for linkage in multiple sclerosis. American Journal of Human Genetics 2005 77 : 454 467.
4. GAMES and Transatlantic Multiple Sclerosis Genetics Cooperative. A meta-analysis of whole genome linkage screens in multiple sclerosis. Journal of Neuroimmunology 2003 143 : 39 46.
5. Dyment DA, Herrera BM, Cader MZ, et al. Complex interactions among MHC haplotypes in multiple sclerosis: susceptibility and resistance. Human Molecular Genetics 2005 14 : 2019 2026.
6. Barcellos LF, Sawcer S, Ramsay PP, et al. Heterogeneity at the HLA-DRB1 locus and risk for multiple sclerosis. Human Molecular Genetics 2006 15 : 2813 2824.
7. Masterman T, Ligers A, Olsson T, Andersson M, Olerup O, Hillert J. HLA-DR15 is associated with lower age at onset in multiple sclerosis. Annals of Neurology 2000 48 : 211 219.
8. Celius EG, Harbo HF, Egeland T, Vartdal F, Vandvik B, Spurkiand A. Sex and age at diagnosis are correlated with the HLA-DR2, DQ6 haplotype in multiple sclerosis. Journal of the Neurological Sciences 2000 178 : 132 135.
9. Hensiek AE, Sawcer SJ, Feakes R, et al. HLA-DR 15 is associated with female sex and younger age at diagnosis in multiple sclerosis. Journal of Neurology, Neurosurgery and Psychiatry 2002 72 : 184 187.
10. Weatherby SJ, Thomson W, Pepper L, et al. HLA-DRB1 and disease outcome in multiple sclerosis. Journal of Neurology 2001 248 : 304 310.
11. Barcellos LF, Oksenberg JR, Begovich AB, et al. HLA-DR2 dose effect on susceptibility to multiple sclerosis and influence on disease course. American Journal of Human Genetics 2003 72 : 710 716.
12. Ballerini C, Guerini FR, Rombola G, et al. HLA-multiple sclerosis association in continental Italy and correlation with disease prevalence in Europe. Journal of Neuroimmunology 2004 150 : 178 185.
13. Olerup O, Hillert J, Fredrikson S, et al. Primarily chronic progressive and relapsing/remitting multiple sclerosis: two immunogenetically distinct disease entities. Proceedings of the National Academy of Sciences of the United States of America 1989 86 : 7113 7117.
14. de la Concha EG, Arroyo R, Crusius JB, et al. Combined effect of HLA-DRB1*1501 and interleukin-1 receptor antagonist gene allele 2 in susceptibility to relapsing/remitting multiple sclerosis. Journal of Neuroimmunology 1997 80 : 172 178.
15. Weinshenker BG, Santrach P, Bissonet AS, et al. Major histocompatibility complex class II alleles and the course and outcome of MS: a population-based study. Neurology 1998 51 : 742 747.
16. Francis DA, Thompson AJ, Brookes P, et al. Multiple sclerosis and HLA: is the susceptibility gene really HLA-DR or -DQ?. Human Immunology 1991 32 : 119 124.
17. Spurkland A, Ronningen KS, Vandvik B, Thorsby E, Vartdal F. HLA-DQA1 and HLA-DQB1 genes may jointly determine susceptibility to develop multiple sclerosis. Human Immunology 1991 30 : 69 75.
18. Lincoln MR, Montpetit A, Cader MZ, et al. A predominant role for the HLA class II region in the association of the MHC region with multiple sclerosis. Nature Genetics 2005 37 : 1108 1112.
19. Fogdell-Hahn A, Ligers A, Gronning M, Hillert J, Olerup O. Multiple sclerosis: a modifying influence of HLA class I genes in an HLA class II associated autoimmune disease. Tissue Antigens 2000 55 : 140 148.
20. Harbo HF, Lie BA, Sawcer S, et al. Genes in the HLA class I region may contribute to the HLA class II-associated genetic susceptibility to multiple sclerosis. Tissue Antigens 2004 63 : 237 247.
21. Rubio JP, Bahlo M, Butzkueven H, et al. Genetic dissection of the human leukocyte antigen region by use of haplotypes of Tasmanians with multiple sclerosis. American Journal of Human Genetics 2002 70 : 1125 1137.
22. Yeo TW, De Jager PL, Gregory SG, et al. A second major histocompatibility complex susceptibility locus for multiple sclerosis. Annals of Neurology 2007 61 : 228 236.
23. Amirzargar AA, Tabasi A, Khosravi F, et al. Optic neuritis, multiple sclerosis and human leukocyte antigen: results of a 4-year follow-up study. European Journal of Neurology 2005 12 : 25 30.
24. Madigand M, Oger JJ, Fauchet R, Sabouraud O, Genetet B. HLA profiles in multiple sclerosis suggest two forms of disease and the existence of protective haplotypes. Journal of the Neurological Sciences 1982 53 : 519 529.
25. Salier JP, Sesboue R, Martin-Mondiere C, et al. Combined influences of Gm and HLA phenotypes upon multiple sclerosis susceptibility and severity. Journal of Clinical Investigation 1986 78 : 533 538.
26. Celius EG, Vandvik B. Multiple sclerosis in Oslo, Norway: prevalence on 1 January 1995 and incidence over a 25-year period. European Journal of Neurology 2001 8 : 463 469.
27. Poser CM, Paty DW, Scheinberg L, et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Annals of Neurology 1983 13 : 227 231.
28. McDonald WI, Compston A, Edan G, et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Annals of Neurology 2001 50 : 121 127.
29. Lublin FD, Reingold SC. Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis. Neurology 1996 46 : 907 911.
30. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983 33 : 1444 1452.
31. Roxburgh RH, Seaman SR, Masterman T, et al. Multiple Sclerosis Severity Score: using disability and disease duration to rate disease severity. Neurology 2005 64 : 1144 1151.
32. Cordell HJ, Clayton DG. A unified stepwise regression procedure for evaluating the relative effects of polymorphisms within a gene using case/control or family data: application to HLA in type 1 diabetes. American Journal of Human Genetics 2002 70 : 124 141.
33. Kruskal WH, Wallis WA. Use of ranks in one-criterion variance analysis. Journal of the American Statistical Association 1952 47 : 583 621.
34. Armitage P, Colton T. Encyclopedia of Biostatistics. Chichester : John Wiley & sons Ltd, 2005.
35. R Foundation for Statistical Computing. R: A Language and Environment for Statistical Computing. Vienna, VA : R Development Core Team, R Foundation for Statistical Computing 2005.
36. Sadovnick AD, Yee IM, Ebers GC, Risch NJ. Effect of age at onset and parental disease status on sibling risks for MS. Neurology 1998 50 : 719 723.
37. Murray KJ, Moroldo MB, Donnelly P, et al. Age-specific effects of juvenile rheumatoid arthritis-associated HLA alleles. Arthritis and Rheumatism 1999 42 : 1843 1853.
38. Valdes AM, Erlich HA, Noble JA. Human leukocyte antigen class I B and C loci contribute to type 1 diabetes (T1D) susceptibility and age at T1D onset. Human Immunology 2005 66 : 301 313.